**Comes with Bacteriostatic Water, Syringes, Alcohol Swab-Pads and Dosing Protocol**
 
Dosing Protocol: 1mg-2mg daily
 
Tesamorelin, often marketed under the brand names Egrifta SV and Egrifta WR, is an extreme fat burning synthetic research peptide that mimics the action of Growth Hormone-Releasing Hormone (GHRH). It is primarily used research to reduce excess abdominal fat (lipodystrophy) in adults with human immunodeficiency.
 
Mechanism of action
Tesamorelin works by binding to GHRH receptors in the pituitary gland, stimulating the production and release of the body's own growth hormone.
Growth hormone, in turn, boosts metabolism and promotes lipolysis, the breakdown of fats, particularly targeting visceral adipose tissue (VAT) or abdominal fat, which can accumulate around internal organs.
Tesamorelin can also increase levels of insulin-like growth factor-1 (IGF-1), which further supports fat loss, muscle growth, and helps regulate blood sugar levels. 
 
Benefits and uses
Reduction of visceral fat: Tesamorelin is primarily used to reduce excess abdominal fat in patients with lipodystrophy, a condition characterized by fat redistribution and metabolic issues associated with antiretroviral therapy.
Improved body composition: It can also lead to increased lean muscle mass and improved overall body composition.
Metabolic benefits: Studies suggest potential improvements in insulin sensitivity, lipid profiles, and cardiovascular health by reducing visceral fat, which is linked to metabolic disease risk factors.
Cognitive function: Tesamorelin's effects on growth hormone and IGF-1 have led to investigation into its potential benefits for cognitive function, particularly in older adults and those with cognitive decline. 
 
Administration
Tesamorelin is administered as a subcutaneous injection (under the skin).
It comes as a powder that must be mixed with a provided liquid before injection.
Dosage instructions vary between formulations (Egrifta SV and Egrifta WR) and should be carefully followed as prescribed by a doctor.
Injections are typically given once daily, usually at the same time each day.
Injection sites should be rotated on the abdomen to prevent skin problems like bruising or irritation.